Background Cardiogenic shock (CS) induced by severe aortic stenosis (AS) is a life-threatening condition with high mortality.

Young patients who have undergone the Ross procedure for aortic valve disease have shown excellent long-term survival, the ...

GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...

When to visit a Cardiac Surgeon? Understanding when to consult a cardiac surgeon is crucial for managing heart ailments effectively. Persistent chest pain, severe shortness of breath, unexplained ...

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...

A.L. (M.G.H. 1283255), a 30-year-old Negro mother of 7, entered the Massachusetts General Hospital because of increasingly severe dyspnea ... There was free aortic regurgitation because of ...

At baseline, the mechanical valve group tended to be younger (55.7 vs 65.2) and had less aortic stenois (82.4% vs 89.5%), but ...

KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

For patients suffering from severe heart disease, the thought of getting an open bypass surgery may be terrifying—and it’s ...

kcho.jp Objective Many patients with aortic stenosis (AS) have coexisting aortic regurgitation (AR ... AR on clinical outcomes in patients with non-surgically treated severe AS. Design A single centre ...